Times Wire Reports

A drug that can selectively target and kill the stem cells that may drive the growth of tumors has been identified.

Researchers at Massachusetts Institute of Technology and the Broad Institute looked for compounds that could destroy the stem cells, which often resist conventional cancer treatment.

One, salinomycin, cut the number of stem cells at least 100 times more than did Taxol, a common chemotherapy medicine, according to a report in the journal Cell.

Copyright © 2019, Los Angeles Times
EDITION: California | U.S. & World